Immunotherapy has emerged as a promising option for many diseases. Immunotherapy is a treatment that uses the body's natural immune system to fight infection and improve health. It uses the body's innate immunity to combat various illnesses, including cancer.
Immunotherapy works by activating T-cells, an immune cell that can recognize and destroy cancer cells. It can target specific cancer cells, sparing healthy cells from being damaged by chemotherapy and radiation.
Immunotherapy can be used as a form of monotherapy to improve the effectiveness of current cancer treatments or as a combination therapy with other treatments, such as radiation and chemotherapy.
Immunotherapy can take many forms, including biological therapy, adoptive cell transfer, and tumor-infiltrating lymphocytes. It is also used with biomarker testing to help identify and target specific cancer cells.
Immune checkpoint inhibitors are a type of immunotherapy that block a cancer cell's ability to hide from the body's immune system and thus allow the body to recognize and attack the cancer cells more efficiently.
T-cell therapy is another type of immunotherapy that introduces modified T-cells into the body to combat specific types of cancer, including lymphoma and leukemia.
CAR-T is a T-cell therapy that engineers the patient's immune cells to recognize and target cancer cells.
Immune system modulators are immunotherapy that modifies the body's natural immune system to recognize better and target cancer cells.
Oncolytic virus therapy is an immunotherapy that uses modified viruses to seek out and destroy cancer cells.
Neutrophil therapy is an immunotherapy that utilizes the body's first line of defense, the neutrophil cells, to attack cancer cells.
Antibody-drug conjugates are a type of immunotherapy that involves attaching cancer-targeting antibodies to a toxic drug, which allows the targeting and destruction of cancer cells without damaging healthy cells.